Parvovirus B19 infection localized in the intestinal mucosa and associated with severe inflammatory bowel disease

Journal of Clinical Microbiology

Volumn 47, Issue 5, 2009, Pages 1591-1595

  Pironi, Loris ^a   Bonvicini, Francesca ^a   Gionchetti, Paolo ^a   D'Errico, Antonia ^a   Rizzello, Fernando ^a   Corsini, Catia ^a   Foroni, Laura ^a   Gallinella, Giorgio ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; COLON BIOPSY; COLON RESECTION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; ENCEPHALITIS; ERYTHEMA INFECTIOSUM; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE MUCOSA; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

COLON; DUODENUM; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; INTESTINAL MUCOSA; MALE; MIDDLE AGED; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; T-LYMPHOCYTES;

PARVOVIRUS;

EID: 66149109250     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.00706-08     Document Type: Article

References (20)

1. Barah, F., P. J. Vallely, G. M. Cleator, and J. R. Kerr. 2003. Neurological manifestations of human parvovirus B19 infection. Rev. Med. Virol. 13:185-199. (Pubitemid 36566087)
2. Bonvicini, F., C. Filippone, E. Manaresi, G. A. Gentilomi, M. Zerbini, M. Musiani, and G. Gallinella. 2006. Peptide nucleic acid-based in situ hybridization assay for detection of parvovirus B19 nucleic acids. Clin. Chem. 52:973-978. (Pubitemid 43794406)
3. Daum, S., C. Cellier, and C. J. Mulder. 2005. Refractory coeliac disease. Best Pract. Res. Clin. Gastroenterol. 19:413-424. (Pubitemid 40753762)
4. Enders, M., G. Schalasta, C. Baisch, A. Weidner, L. Pukkila, L. Kaikkonen, H. Lankinen, L. Hedman, M. Soderlund-Venermo, and K. Hedman. 2006. Human parvovirus B19 infection during pregnancy - value of modern molecular and serological diagnostics. J. Clin. Virol. 35:400-406. (Pubitemid 43324836)
5. Fu, Y., K. K. Ishii, Y. Munakata, T. Saitoh, M. Kaku, and T. Sasaki. 2002. Regulation of tumor necrosis factor alpha promoter by human parvovirus B19 NS1 through activation of AP-1 and AP-2. J. Virol. 76:5395-5403. (Pubitemid 34517890)
6. Gallinella, G., F. Bonvicini, C. Filippone, S. Delbarba, E. Manaresi, M. Zerbini, and M. Musiani. 2004. Calibrated real-time PCR for evaluation of parvovirus b19 viral load. Clin. Chem. 50:759-762. (Pubitemid 38429344)
7. Gallinella, G., E. Zuffi, G. Gentilomi, E. Manaresi, S. Venturoli, F. Bonvicini, M. Cricca, M. Zerbini, and M. Musiani. 2003. Relevance of B19 markers in serum samples for a diagnosis of parvovirus B19-correlated diseases. J. Med. Virol. 71:135-139. (Pubitemid 37121923)
8. Greco, L., R. Romino, I. Coto, N. Di Cosmo, S. Percopo, M. Maglio, F. Paparo, V. Gasperi, M. G. Limongelli, R. Cotichini, C. D'Agate, N. Tinto, L. Sacchetti, R. Tosi, and M. A. Stazi. 2002. The first large population based twin study of coeliac disease. Gut 50:624-628.
9. Kerr, J. R., F. Barah, M. L. Chiswick, G. V. McDonnell, J. Smith, M. D. Chapman, J. B. Bingham, P. Kelleher, and M. N. Sheppard. 2002. Evidence for the role of demyelination, HLA-DR alleles, and cytokines in the pathogenesis of parvovirus B19 meningoencephalitis and its sequelae. J. Neurol. Neurosurg. Psychiatry 73:739-746.
10. Kerr, J. R., D. L. Mattey, W. Thomson, K. V. Poulton, and W. E. Ollier. 2002. Association of symptomatic acute human parvovirus B19 infection with human leukocyte antigen class I and II alleles. J. Infect. Dis. 186:447-452.
11. Lamps, L. W. 2007. Infective disorders of the gastrointestinal tract. Histopathology 50:55-63.
12. Moffatt, S., N. Tanaka, K. Tada, M. Nose, M. Nakamura, O. Muraoka, T. Hirano, and K. Sugamura. 1996. A cytotoxic nonstructural protein, NS1, of human parvovirus B19 induces activation of interleukin-6 gene expression. J. Virol. 70:8485-8491.
13. Munakata, Y., T. Saito-Ito, K. Kumura-Ishii, J. Huang, T. Kodera, T. Ishii, Y. Hirabayashi, Y. Koyanagi, and T. Sasaki. 2005. Ku80 autoantigen as a cellular coreceptor for human parvovirus B19 infection. Blood 106:3449-3456.
14. Musiani, M., G. Gallinella, S. Venturoli, and M. Zerbini. 2007. Competitive PCR-ELISA protocols for the quantitative and the standardized detection of viral genomes. Nat. Protoc. 2:2511-2519.
15. Pasquinelli, G., F. Bonvicini, L. Foroni, N. Salfi, and G. Gallinella. 2009. Placental endothelial cells can be productively infected by parvovirus B19. J. Clin. Virol. 44:33-38.
16. Sollid, L. M., and B. A. Lie. 2005. Celiac disease genetics: current concepts and practical applications. Clin. Gastroenterol. Hepatol. 3:843-851.
17. Stokkers, P. C., P. H. Reitsma, G. N. Tytgat, and S. J. van Deventer. 1999. HLA-DR and -DQ phenotypes in inflammatory bowel disease: a metaanalysis. Gut 45:395-401.
18. Takahashi, Y., C. Murai, S. Shibata, Y. Munakata, T. Ishii, K. Ishii, T. Saitoh, T. Sawai, K. Sugamura, and T. Sasaki. 1998. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 95:8227-8232.
19. Watanabe, T. 2004. Ulcerative colitis that developed 8 years after human parvovirus B19 encephalopathy. Eur. J. Pediatr. 163:341-342. (Pubitemid 38725547)
20. Young, N. S., and K. E. Brown. 2004. Parvovirus B19. N. Engl. J. Med. 350:586-597.